The Relationship between Human Papillomavirus and Anxiety, Depression, and Sexual Dysfunction in Women

Year 2022, Volume: 39 Issue: 4, 999 - 1003, 29.10.2022

Naziye Gürkan , Tuğba Gürbüz

Abstract

We aimed to investigate the impact of Human Papillomavirus (HPV) positivity on women’s mental health and sexual dysfunction (SD). Anxiety, hopelessness, and depression were investigated in this study as common psychological problems. This prospective cross-sectional case-control study was done on 213 participants who attended gynecology clinic from February 2021 to May 2022. The Turkish version of Female Sexual Function Index (FSFI)-6 was used to measure SD in women. The Turkish version of Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Beck Hopelessness Scale (BHS) was used to measure depression, anxiety and hopelessness in women. According to the HPV test results, the subjects were divided into two groups: 1st group as HPV positive and 2nd group as HPV negative. 97 women in the 1st group and 116 patients in the 2nd group were included in the study. The participants’ age and body mass index (BMI) were 33.91±3.74 and 24.88±3.01, respectively. There was a significant difference between the women with HPV-positive and HPV-negative in FSFI total scores and all subdomains (p-value<0.05). There was a significant difference in BDI, BHS, and BAI (p-value<0.05). There was a significant correlation between the FSFI and BAI in HPV-positive. There was a significant correlation between the FSFI and BAI in HPV-negative. There was a significant correlation between the FSFI and BDI in HPV-negative. The health system should support women with HPV in terms of mental health. These women are more exposed to depression, anxiety, hopelessness, and SD.

Keywords

Human Papillomavirus, Female Sexual Function Index, Sexual Dysfunction, Quality of Life

References

• 1. Preston SM, Darrow WW. Improving human papillomavirus-related knowledge and attitudes among ethnically diverse young adults. Health Equity 2019; 3: 254-63.
• 2. Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017; 131: 2201-21.
• 3. Shanmugasundaram S, You J. Targeting persistent human papillomavirus infection. Viruses 2017; 9: 229.
• 4. Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2021; 8: 552028.
• 5. Hancer VS, Buyukdogan M, Bylykbashi I, Oksuz B, Acar M. Prevalence of human papilloma virus types in Turkish and Albanian women. J Cytol 2018; 35: 252-4.
• 6. Alay I, Kaya C, Karaca I, Yildiz S, Baghaki S, Cengiz H, et al. The effect of being diagnosed with human papillomavirus infection on women's sexual lives. J Med Virol. 2020; 92(8): 1290-7.
• 7. Markovic-Denic L, Djuric O, Maksimovic N, Popovac S, Kesic V. Effects of human papillomavirus awareness and knowledge on psychological state of women referred to cervical cancer screening. J Low Genit Tract Dis 2018; 22: 178-83.
• 8. Ngu SF, Wei N, Kwan TTC, Chu MMY, Tse KY, Chan KKL, et al. Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial. J Psychosom Obstet Gynaecol. 2018; 39(2): 146-55.
• 9. de Kok IMCM, Korfage IJ, van den Hout WB, Helmerhorst TJM, Habbema JDF, Essink-Bot ML,et al. Quality of life assumptions determine which cervical cancer screening strategies are cost-effective. Int J Cancer. 2018; 142(11): 2383-93.
• 10. Omani-Samani R, Amini P, Navid B, Sepidarkish M, Maroufizadeh S, Almasi-Hashiani A. Prevalence of sexual dysfunction among infertile women in iran: a systematic review and meta-analysis. Int J Fertil Steril 2019; 12: 278-83.
• 11. Aygin D, ETİ FA. Kadın cinsel işlev ölçeği’nin Türkçeye uyarlaması. Türkiye Klinikleri Tıp Bilimleri Dergisi 2005; 25: 393-9.
• 12. Hisli N. Beck Depresyon Envanterinin gecerliligi uzerine bit calisma (A study on the validity of Beck Depression Inventory.). Psikoloji Dergisi 1988; 6: 118-22.
• 13. Ulusoy M, Sahin NH, and Erkmen H. Turkish version Of The Beck Anxiety Inventory: Psychometric Properties. J Cognitive Psychother 1998; 12: 163.
• 14. Durak A, Palabiyikoğlu R. Beck umutsuzluk ölçeği geçerlilik çalişmasi. Kriz Dergisi 1994; 2: 311-9.
• 15. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91.
• 16. Lin H, Jeng CJ, Wang LR. Psychological responses of women infected with cervical human papillomavirus: a qualitative study in Taiwan. Taiwan J Obstet Gynecol 2011; 50: 154-8.
• 17. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004; 111: 1437-43.
• 18. Li CC. The Impact of HPV Diagnosis on Taiwanese Women's Quality of Life and Sexual Health. Sigma's 30th International Nursing Research Congress, 2019.
• 19. Dominiak-Felden G, Cohet C, Atrux-Tallau S, Gilet H, Tristram A, Fiander A. Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health 2013; 13: 1065.
• 20. Mercan R, Mercan S, Durmaz B, Sur H, Kilciksiz CM, Kacar AS, et al. Sexual dysfunction in women with human papilloma virus infection in the Turkish population. J Obstet Gynaecol. 2019; 39(5): 659-63.
• 21. Heinonen A, Tapper AM, Leminen A, Sintonen H, Roine RP. Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: an observational study. Eur J Obstet Gynecol Reprod Biol 2013; 169: 387-91.
• 22. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 2004; 328: 1293.
• 23. Waller J, Marlow LA, Wardle J. The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex Transm Infect 2007; 83: 155-9.
• 24. Uzun SB, Sakin Ö, Çetin H, Şimşek EE. The Effects of HPV Test on Anxiety, Emotion and Depression in Women. J Acad Res Med 2020; 10: 149-54.
• 25. Rask M, Swahnberg K, Oscarsson M. Swedish women's awareness of human papillomavirus, and health-related quality of life, anxiety, and depression after a notification of an abnormal Pap smear result: a cross-sectional study. Eur J Cancer Prev 2019; 28: 96-101.
• 26. Ferenidou F, Salakos N, Vaidakis N, Paltoglou G, Bakalianou K, Papadimitriou G,et al. The impact of HPV diagnosis on women's sexual and mental health: preliminary findings. Clin Exp Obstet Gynecol 2012; 39: 79-82.
• 27. Caruso S, Bruno mt, cianci s, di pasqua s, minona p, cianci a. sexual Behavior of Women With Diagnosed HPV. J Sex Marital Ther 2019; 45: 569-73.
• 28. Ekmez M, Ekmez F. Effects of HPV Positivity In Women On Couples Sexual Behavior. J Sex Marital Ther 2022: 1-8.
• 29. Fornage S, Schweizer A, Lepigeon K, Bianchi Demicheli F, Faouzi M, Jacot-Guillarmod M. Is women's sexual function impaired by an abnormal pap smear? Eur J Contracept Reprod Health Care 2022; 27: 184-8.
• 30. Ilgen O, Kurt S, Kula H, Celiloglu M. Sexual dysfunction in women who are human papillomavirus positive. J Reprod Med Gynecol Obstet 2020; 5: 61.